Advertisement

Topics

Redx Pharma appoints chief medical officer who will oversee launch of phase I clinical trial of new cancer drug

03:01 EST 22 Jan 2018 | Proactive Investors

Dr Andrew Saunders has 25 years in the cancer field and was recruited from Lytix Biopharma

Original Article: Redx Pharma appoints chief medical officer who will oversee launch of phase I clinical trial of new cancer drug

NEXT ARTICLE

More From BioPortfolio on "Redx Pharma appoints chief medical officer who will oversee launch of phase I clinical trial of new cancer drug"

Quick Links
Advanced Search | Login | Subscribe | RSS

Quick Search
Advertisement

 

Relevant Topic

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...


News Quicklinks

Search Biotech, Medical and Healthcare News

Popular Biotech, Medical and Healthcare News

Biotech News by Article Type

BioPortfolio Bloggers

Publishing Your News on BioPortfolio

Recent Visitor News Searches

BioPortfolio Limited Social Media
Publish Content Agreements
Tools Help

HON Code certificate This site complies with the HONcode standard for trustworthy health information:
Verify here.

The information provided by BioPortfolio.com is not a substitute for professional medical advice, diagnosis or treatment. The BioPortfolio site is sponsored BioPortfolio Limited with offices at Stafford House, 10 Prince of Wales Road, Dorchester, DT1 1PW, England. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of “Fair Use” and legitimately infringes on your or your client's copyright we may be contacted concerning copyright matters here: Contact BioPortfolio.
All rights reserved. All other trademarks recognized. Copyright © 1997-2018 BioPortfolio Limited. Site developed by Alacrify Ltd.